Nuveen Fund Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,712
Closed -$325K 301
2017
Q4
$325K Sell
1,712
-693
-29% -$133K 0.09% 227
2017
Q3
$455K Sell
2,405
-269
-10% -$48.7K 0.09% 234
2017
Q2
$467K Sell
2,674
-266
-9% -$44.7K 0.07% 275
2017
Q1
$452K Buy
2,940
+613
+26% +$93.7K 0.06% 304
2016
Q4
$328K Buy
2,327
+999
+75% +$147K 0.05% 353
2016
Q3
$211K Buy
+1,328
New +$205K 0.03% 425

Other funds holding TMO

Nuveen Fund Advisors's TMO Position: Q1 2018 in Review

Nuveen Fund Advisors sold out of Thermo Fisher Scientific (TMO) in Q1 2018, closing a stake of 1,712 shares — an estimated $325K sold.

Nuveen Fund Advisors first reported a position in TMO in Q3 2016 and held it in 6 quarters. The position peaked at $467K in Q2 2017. 1,305 funds tracked by Wall St. Rank hold TMO as of Q1 2018.

  • Nuveen Fund Advisors reported no remaining Thermo Fisher Scientific position as of Q1 2018 after selling out during the quarter.
  • Nuveen Fund Advisors sold 1,712 Thermo Fisher Scientific shares in Q1 2018, an estimated $325K.
  • Nuveen Fund Advisors first reported a position in Thermo Fisher Scientific in Q3 2016 and held it in 6 quarters.
  • Nuveen Fund Advisors's Thermo Fisher Scientific position peaked at $467K in Q2 2017.
  • 1,305 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2018.

Based on Nuveen Fund Advisors's 13F filing for Q1 2018, filed 14 May 2018.